Siemens Healthineers AG has CE marked a SARS-CoV-2 IgG antibody test, which it claims is the first diagnostic from a major IVD company to measure the quantity of neutralizing antibodies. This will be important in measuring the effectiveness of COVID-19 vaccines and determining whether broad vaccination programs are working. The company has submitted the test to the US Food and Drug Administration under an emergency use authorization.
There are numerous quantitative tests for SARS-CoV-2 antibodies available, but Siemens Healthineers claims other quantitative tests from major suppliers do...